SYNB1618

DRUG3 trials

Sponsors

Synlogic

Conditions

HealthyPhenylketonuria

Phase 1

Safety and Tolerability of SYNB1618 in Healthy Adult Volunteers and Adult Subjects With Phenylketonuria

CompletedNCT03516487

SynlogicHealthy, Phenylketonuria

Start: 2018-04-17End: 2019-06-21Updated: 2021-05-13

Safety and Tolerability of SYNB1934 in Healthy Adult Volunteers

CompletedNCT04984525

SynlogicHealthy

Start: 2021-07-02End: 2021-12-10Updated: 2022-05-18

Phase 2

Efficacy and Safety of SYNB1618 and SYNB1934 in Adult Patients With Phenylketonuria

CompletedNCT04534842

SynlogicPhenylketonuria

Start: 2020-08-25End: 2022-10-07Updated: 2022-10-17

Related Papers

Efficacy and safety of a synthetic biotic for treatment of phenylketonuria: a phase 2 clinical trial.

2023-09-2835 citations

Safety and pharmacodynamics of an engineered E. coli Nissle for the treatment of phenylketonuria: a first-in-human phase 1/2a study.

2021-07-22104 citations